240 related articles for article (PubMed ID: 27197274)
1. Parity and Oral Contraceptive Use in Relation to Ovarian Cancer Risk in Older Women.
McGuire V; Hartge P; Liao LM; Sinha R; Bernstein L; Canchola AJ; Anderson GL; Stefanick ML; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1059-63. PubMed ID: 27197274
[TBL] [Abstract][Full Text] [Related]
2. Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use.
Gnagy S; Ming EE; Devesa SS; Hartge P; Whittemore AS
Epidemiology; 2000 Mar; 11(2):102-5. PubMed ID: 11021604
[TBL] [Abstract][Full Text] [Related]
3. Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.
Kolomeyevskaya NV; Szender JB; Zirpoli G; Minlikeeva A; Friel G; Cannioto RA; Brightwell RM; Grzankowski KS; Moysich KB
Int J Gynecol Cancer; 2015 Nov; 25(9):1587-92. PubMed ID: 26273932
[TBL] [Abstract][Full Text] [Related]
4. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer.
Rosenberg L; Palmer JR; Zauber AG; Warshauer ME; Lewis JL; Strom BL; Harlap S; Shapiro S
Am J Epidemiol; 1994 Apr; 139(7):654-61. PubMed ID: 8166126
[TBL] [Abstract][Full Text] [Related]
5. Identifying post-menopausal women at elevated risk for epithelial ovarian cancer.
Urban N; Hawley S; Janes H; Karlan BY; Berg CD; Drescher CW; Manson JE; Palomares MR; Daly MB; Wactawski-Wende J; O'Sullivan MJ; Thorpe J; Robinson RD; Lane D; Li CI; Anderson GL
Gynecol Oncol; 2015 Nov; 139(2):253-60. PubMed ID: 26343159
[TBL] [Abstract][Full Text] [Related]
6. Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness.
Poole EM; Merritt MA; Jordan SJ; Yang HP; Hankinson SE; Park Y; Rosner B; Webb PM; Cramer DW; Wentzensen N; Terry KL; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):429-37. PubMed ID: 23307531
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting the association of oral contraceptives and ovarian cancer.
Cramer DW; Hutchison GB; Welch WR; Scully RE; Knapp RC
N Engl J Med; 1982 Oct; 307(17):1047-51. PubMed ID: 7121514
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.
Tsilidis KK; Allen NE; Key TJ; Dossus L; Lukanova A; Bakken K; Lund E; Fournier A; Overvad K; Hansen L; Tjønneland A; Fedirko V; Rinaldi S; Romieu I; Clavel-Chapelon F; Engel P; Kaaks R; Schütze M; Steffen A; Bamia C; Trichopoulou A; Zylis D; Masala G; Pala V; Galasso R; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; van Duijnhoven FJ; Braem MG; Onland-Moret NC; Gram IT; Rodríguez L; Travier N; Sánchez MJ; Huerta JM; Ardanaz E; Larrañaga N; Jirström K; Manjer J; Idahl A; Ohlson N; Khaw KT; Wareham N; Mouw T; Norat T; Riboli E
Br J Cancer; 2011 Oct; 105(9):1436-42. PubMed ID: 21915124
[TBL] [Abstract][Full Text] [Related]
9. Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study.
Bešević J; Gunter MJ; Fortner RT; Tsilidis KK; Weiderpass E; Onland-Moret NC; Dossus L; Tjønneland A; Hansen L; Overvad K; Mesrine S; Baglietto L; Clavel-Chapelon F; Kaaks R; Aleksandrova K; Boeing H; Trichopoulou A; Lagiou P; Bamia C; Masala G; Agnoli C; Tumino R; Ricceri F; Panico S; Bueno-de-Mesquita HB; Peeters PH; Jareid M; Quirós JR; Duell EJ; Sánchez MJ; Larrañaga N; Chirlaque MD; Barricarte A; Dias JA; Sonestedt E; Idahl A; Lundin E; Wareham NJ; Khaw KT; Travis RC; Rinaldi S; Romieu I; Riboli E; Merritt MA
Br J Cancer; 2015 Dec; 113(11):1622-31. PubMed ID: 26554655
[TBL] [Abstract][Full Text] [Related]
10. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
[TBL] [Abstract][Full Text] [Related]
11. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
[TBL] [Abstract][Full Text] [Related]
12. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.
Wentzensen N; Poole EM; Trabert B; White E; Arslan AA; Patel AV; Setiawan VW; Visvanathan K; Weiderpass E; Adami HO; Black A; Bernstein L; Brinton LA; Buring J; Butler LM; Chamosa S; Clendenen TV; Dossus L; Fortner R; Gapstur SM; Gaudet MM; Gram IT; Hartge P; Hoffman-Bolton J; Idahl A; Jones M; Kaaks R; Kirsh V; Koh WP; Lacey JV; Lee IM; Lundin E; Merritt MA; Onland-Moret NC; Peters U; Poynter JN; Rinaldi S; Robien K; Rohan T; Sandler DP; Schairer C; Schouten LJ; Sjöholm LK; Sieri S; Swerdlow A; Tjonneland A; Travis R; Trichopoulou A; van den Brandt PA; Wilkens L; Wolk A; Yang HP; Zeleniuch-Jacquotte A; Tworoger SS
J Clin Oncol; 2016 Aug; 34(24):2888-98. PubMed ID: 27325851
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of reproductive factors and exogenous hormone use in relation to ovarian cancer risk among Black women.
Bethea TN; Palmer JR; Adams-Campbell LL; Rosenberg L
Cancer Causes Control; 2017 May; 28(5):385-391. PubMed ID: 28025764
[TBL] [Abstract][Full Text] [Related]
14. The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age.
Villard-Mackintosh L; Vessey MP; Jones L
Br J Obstet Gynaecol; 1989 Jul; 96(7):783-8. PubMed ID: 2788456
[TBL] [Abstract][Full Text] [Related]
15. Hormonal risk factors and invasive epithelial ovarian cancer risk by parity.
Bodelon C; Wentzensen N; Schonfeld SJ; Visvanathan K; Hartge P; Park Y; Pfeiffer RM
Br J Cancer; 2013 Aug; 109(3):769-76. PubMed ID: 23820255
[TBL] [Abstract][Full Text] [Related]
16. Personal characteristics relating to risk of invasive epithelial ovarian cancer in older women in the United States.
Whittemore AS
Cancer; 1993 Jan; 71(2 Suppl):558-65. PubMed ID: 8420677
[TBL] [Abstract][Full Text] [Related]
17. Combined oral contraceptive use before the first birth and epithelial ovarian cancer risk.
Cook LS; Pestak CR; Leung AC; Steed H; Nation J; Swenerton K; Gallagher R; Magliocco A; Köbel M; Brooks-Wilson A; Le N
Br J Cancer; 2017 Jan; 116(2):265-269. PubMed ID: 27959890
[TBL] [Abstract][Full Text] [Related]
18. Parity, contraception, infertility, and the risk of epithelial ovarian cancer.
Risch HA; Marrett LD; Howe GR
Am J Epidemiol; 1994 Oct; 140(7):585-97. PubMed ID: 7942759
[TBL] [Abstract][Full Text] [Related]
19. Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group.
John EM; Whittemore AS; Harris R; Itnyre J
J Natl Cancer Inst; 1993 Jan; 85(2):142-7. PubMed ID: 8418303
[TBL] [Abstract][Full Text] [Related]
20. Events of reproductive life and the incidence of epithelial ovarian cancer.
Risch HA; Weiss NS; Lyon JL; Daling JR; Liff JM
Am J Epidemiol; 1983 Feb; 117(2):128-39. PubMed ID: 6681935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
